[HTML][HTML] To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson's disease
C Rusch, R Flanagan, H Suh, I Subramanian - npj Parkinson's Disease, 2023 - nature.com
Administration of levodopa for Parkinson's disease (PD) has remained the most effective
therapy for symptom management despite being in use for over 50 years. Advancing …
therapy for symptom management despite being in use for over 50 years. Advancing …
To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson's disease.
C Rusch, R Flanagan, H Suh… - NPJ Parkinson's …, 2023 - europepmc.org
Administration of levodopa for Parkinson's disease (PD) has remained the most effective
therapy for symptom management despite being in use for over 50 years. Advancing …
therapy for symptom management despite being in use for over 50 years. Advancing …
[HTML][HTML] To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson's disease
C Rusch, R Flanagan, H Suh… - NPJ Parkinson's …, 2023 - ncbi.nlm.nih.gov
Administration of levodopa for Parkinson's disease (PD) has remained the most effective
therapy for symptom management despite being in use for over 50 years. Advancing …
therapy for symptom management despite being in use for over 50 years. Advancing …
To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson's disease
C Rusch, R Flanagan, H Suh… - NPJ Parkinson's …, 2023 - pubmed.ncbi.nlm.nih.gov
Administration of levodopa for Parkinson's disease (PD) has remained the most effective
therapy for symptom management despite being in use for over 50 years. Advancing …
therapy for symptom management despite being in use for over 50 years. Advancing …
To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson's disease
C Rusch, R Flanagan, H Suh… - NPJ Parkinson's …, 2023 - search.proquest.com
Administration of levodopa for Parkinson's disease (PD) has remained the most effective
therapy for symptom management despite being in use for over 50 years. Advancing …
therapy for symptom management despite being in use for over 50 years. Advancing …
To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson's disease.
C Rusch, R Flanagan, H Suh… - NPJ Parkinson's …, 2023 - search.ebscohost.com
Administration of levodopa for Parkinson's disease (PD) has remained the most effective
therapy for symptom management despite being in use for over 50 years. Advancing …
therapy for symptom management despite being in use for over 50 years. Advancing …
[引用][C] To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson's disease
C Rusch, R Flanagan, H Suh, I Subramanian - europepmc.org
Often utilized early and throughout the course of Parkinson's disease (PD), orally
administered levodopa (3, 4-dihydroxy-L-phenylalanine) is a precursor for dopamine and …
administered levodopa (3, 4-dihydroxy-L-phenylalanine) is a precursor for dopamine and …